Miyawaki; Nobuaki
Patent Applications and Registrations
Patent applications and USPTO patent grants for Miyawaki; Nobuaki.The latest application filed is for "remedy for glaucoma comprising as the active ingredient compound having p13 kinase inhibitory effect".
- Miyawaki; Nobuaki - Hyogo JP
- Miyawaki, Nobuaki - Ikoma-shi JP
- Miyawaki, Nobuaki - Ikoma JP
- Miyawaki; Nobuaki - Sanda JP
| Patent | Date |
|---|---|
| Agent for protection of retinal neurons Grant 7,153,837 - Ishigaki , et al. December 26, 2 | 2006-12-26 |
| Remedy for glaucoma comprising as the active ingredient compound having p13 kinase inhibitory effect App 20040242545 - Otsuka, Yoshihisa ; et al. | 2004-12-02 |
| Optic nerve protecting agents containing alpha1 receptor blocker as active ingredient App 20040192699 - Miyawaki, Nobuaki ; et al. | 2004-09-30 |
| Agent for protection of retinal neurons App 20040171558 - Ishigaki, Kaoru ; et al. | 2004-09-02 |
| Remedies for ophthalmic diseases App 20030007971 - Hara, Hideaki ; et al. | 2003-01-09 |
| 1,3-dialkylurea derivative Grant 5,968,980 - Kawashima , et al. October 19, 1 | 1999-10-19 |
| 1,3-dialkylurea derivatives having a hydroxyl group Grant 5,891,912 - Kawashima , et al. April 6, 1 | 1999-04-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 